Print this page
Contact us
Board
Grahame COOK, Non-Executive Director
Grahame Cook joined the Board in 2004. He has over 18 years’ experience in investment banking, advising on a wide number of mergers and acquisitions and capital market transactions in the US and Europe. He was Global CEO of West LB Panmure, where he joined in 1999, Managing Director of Capital Markets and on the Global Investment Banking Committee at UBS. He has advised on a number of transactions in the pharmaceuticals and biotechnology sectors across Europe and the US, including private equity investments, IPOs and secondary offerings. Grahame Cook was a founder member of the LSE’s TechMARK Advisory Committee, and holds an MA, double first, from Oxford University. He is currently a Non-Executive Director of Antisonna plc.
Chris SPOONER, Chief Executive Officer
Chris Spooner was appointed CEO of Sinclair Pharma in December 2009. He has 15 years’ experience in analysing and investing in life science companies, having been a top-rated pharmaceuticals analyst at various investment banks, including JP Morgan, Deutsche Bank, Donaldson Lufkin & Jenrette and Bank of America. Prior to joining Sinclair he was the founding partner and CEO of HealthCor Management UK LLP, the European division of HealthCor LP, a leading New York based specialist healthcare fund. He holds an MA in Economics from King’s College, Cambridge.
Penny FREER, Senior Independent Director
Penny Freer joined the Board in January 2006. She has over 20 years’ experience in investment banking, advising companies on a wide variety of issues, including their interaction with the capital markets. From 2000 she was Head of Equities for Robert W. Baird in London, previously she was responsible for Credit Lyonnais Securities’ small and mid cap equities activities. In 2004 she co-founded Capital Markets Group, an FSA authorised corporate advisory and investor relations business. She is currently a non-executive director of Empresaria Group plc and has recently been appointed onto the Board of Advanced Medical Solutions Group plc.
Jean-Charles TSCHUDIN, Non-Executive Director
Jean-Charles Tschudin joined the Board in November 2007. He has extensive experience in the pharmaceutical industry at a senior executive level on three continents. He was recently President and Chief Operating Officer of Yamanouchi Europe, the largest Japanese company in Europe (now Astellas). He has also held senior positions at Johnson & Johnson, Schering-Plough, Syntex and Cardinal Health. Jean-Charles Tschudin is currently Non-Executive Director of SkyePharma plc and he also consults for the pharma industry.
Christophe FOUCHER, Chief Operating Officer
Christophe Foucher joined the Board of Sinclair in December 2009, having been appointed Chief Operating Officer in May 2009. He is responsible for all commercial supply chain and manufacturing activities in the Group. Prior to this he held the positions of General Manager for Sinclair Pharma France and Southern Europe Director, in charge of operations in Italy and Spain. Christophe Foucher has 17 years' experience in the pharmaceutical industry at senior level in Europe, Africa and Asia. He has a doctorate degree in Pharmacy, an INSEAD diploma in Finance and an MBA from IAE. He is fluent in English, French and Italian.